Showing results (5051-5060 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 24, 2012
Molecular markers of cardiovascular damage in hypertensionChiara Armani, Nicoletta Botto, Maria Grazia Andreassi, et al.Current Pharmaceutical Design|November 24, 2012
Microvascular function/dysfunction downstream a coronary stenosisGiacinta Guarini, Paola Giuseppina Capozza, Alda Huqi, et al.Current Pharmaceutical Design|November 24, 2012
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure stateGuido Grassi, Silvia Buzzi, Raffaella Dell'Oro, et al.Current Pharmaceutical Design|November 24, 2012
Device-based therapies for resistant hypertensionRosa Maria Bruno, Alessia Di Giulio, Giampaolo Bernini, et al.Current Pharmaceutical Design|November 24, 2012
Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic riskSerena Del Turco, Melania Gaggini, Giuseppe Daniele, et al.Current Pharmaceutical Design|May 29, 2012
Context-dependent action of transforming growth factor β family members on normal and cancer stem cellsLaia Caja, Kaoru Kahata, Aristidis MoustakasCurrent Pharmaceutical Design|May 29, 2012
Deregulated bone morphogenetic protein receptor signaling underlies fibrodysplasia ossificans progressivaDavid J J de Gorter, Vishant Jankipersadsing, Peter Ten DijkeCurrent Pharmaceutical Design|May 29, 2012
TGF-beta inihibitor-loaded polyelectrolyte multilayers capsules for sustained targeting of hepatocarcinoma cellsViviana Vergaro, Francesca Baldassarre, Flavia De Santis, et al.Current Pharmaceutical Design|May 29, 2012
TGF-β in epithelial to mesenchymal transition and metastasis of liver carcinomaPatrick Reichl, Christine Haider, Markus Grubinger, et al.Current Pharmaceutical Design|May 29, 2012
Oral HPV infection: current strategies for prevention and therapyStina Syrjanen, Nicoletta Termine, Giuseppa Capra, et al.Pageof 1,008